OraSure Technologies - 26 Year Stock Price History | OSUR
Historical daily share price chart and data for OraSure Technologies since 1992 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for OraSure Technologies as of October 19, 2018 is 14.77.
| OraSure Technologies Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2018 | 17.2023 | 19.2900 | 22.0400 | 14.1000 | 14.7700 | -21.69% |
| 2017 | 15.7649 | 8.7900 | 22.8100 | 8.4800 | 18.8600 | 114.81% |
| 2016 | 7.2931 | 6.3500 | 9.3700 | 5.1800 | 8.7800 | 36.34% |
| 2015 | 6.3313 | 9.9500 | 10.5200 | 4.4400 | 6.4400 | -36.49% |
| 2014 | 7.7533 | 6.4700 | 10.5300 | 5.5300 | 10.1400 | 61.21% |
| 2013 | 5.4950 | 7.2500 | 7.3700 | 3.7900 | 6.2900 | -12.40% |
| 2012 | 10.0560 | 9.5100 | 13.3800 | 6.6900 | 7.1800 | -21.19% |
| 2011 | 8.0305 | 6.0100 | 9.9900 | 6.0100 | 9.1100 | 58.43% |
| 2010 | 4.8892 | 5.2900 | 6.7700 | 3.2500 | 5.7500 | 13.19% |
| 2009 | 3.1958 | 3.6600 | 5.1900 | 2.2500 | 5.0800 | 38.04% |
| 2008 | 5.3908 | 8.7200 | 9.1100 | 2.4300 | 3.6800 | -58.61% |
| 2007 | 8.5124 | 8.1500 | 10.5200 | 7.0400 | 8.8900 | 7.63% |
| 2006 | 8.8518 | 9.1200 | 11.5000 | 6.2500 | 8.2600 | -6.35% |
| 2005 | 8.8830 | 6.6000 | 13.9400 | 5.4300 | 8.8200 | 31.25% |
| 2004 | 7.6589 | 7.9200 | 10.5000 | 5.2000 | 6.7200 | -15.58% |
| 2003 | 7.7223 | 5.6400 | 10.7900 | 5.3800 | 7.9600 | 46.06% |
| 2002 | 5.9586 | 12.2000 | 12.2000 | 3.6500 | 5.4500 | -55.14% |
| 2001 | 10.1882 | 7.5310 | 14.7400 | 6.5000 | 12.1500 | 47.27% |
| 2000 | 10.8315 | 6.4400 | 17.0000 | 5.8750 | 8.2500 | 26.92% |
| 1999 | 5.6113 | 6.0000 | 7.8800 | 4.0000 | 6.5000 | 10.73% |
| 1998 | 5.3131 | 5.3800 | 6.8800 | 3.0000 | 5.8700 | 17.40% |
| 1997 | 8.7378 | 12.1200 | 16.2500 | 4.5000 | 5.0000 | -56.52% |
| 1996 | 15.5263 | 15.2500 | 21.5000 | 11.1200 | 11.5000 | -30.30% |
| 1995 | 15.5519 | 21.2500 | 21.2500 | 9.8800 | 16.5000 | -22.83% |
| 1994 | 18.1950 | 20.5000 | 24.8800 | 14.0000 | 21.3800 | 4.91% |
| 1993 | 19.4374 | 19.1200 | 23.6200 | 16.2500 | 20.3800 | 13.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.904B | $0.167B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $126.867B | 19.45 |
| Abbott Laboratories (ABT) | United States | $118.574B | 24.05 |
| Stryker (SYK) | United States | $63.182B | 24.41 |
| Boston Scientific (BSX) | United States | $50.532B | 26.29 |
| Baxter (BAX) | United States | $37.110B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.314B | 16.26 |
| ResMed (RMD) | United States | $14.694B | 29.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.608B | 0.00 |
| Canopy Growth (CGC) | Canada | $10.780B | 0.00 |
| Perrigo (PRGO) | Ireland | $9.837B | 13.96 |
| Bio-Rad Laboratories (BIO) | United States | $8.382B | 53.82 |
| Hill-Rom Holdings (HRC) | United States | $5.797B | 19.66 |
| Haemonetics (HAE) | United States | $5.495B | 50.15 |
| ICU Medical (ICUI) | United States | $5.418B | 36.71 |
| Insulet (PODD) | United States | $5.203B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.301B | 0.00 |
| Hutchison China MediTech (HCM) | China | $4.012B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.879B | 0.00 |
| Neogen (NEOG) | United States | $3.281B | 49.69 |
| NuVasive (NUVA) | United States | $3.191B | 30.27 |
| National Vision Holdings (EYE) | United States | $3.137B | 69.28 |
| Quidel (QDEL) | United States | $2.525B | 51.73 |
| NxStage Medical (NXTM) | United States | $1.815B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.784B | 25.40 |
| Cardiovascular Systems (CSII) | United States | $1.263B | 727.80 |
| AtriCure (ATRC) | United States | $1.071B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.985B | 16.09 |
| Owens & Minor (OMI) | United States | $0.934B | 9.99 |
| Cerus (CERS) | United States | $0.887B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.874B | 25.81 |
| PetIQ (PETQ) | United States | $0.862B | 28.18 |
| Surmodics (SRDX) | United States | $0.843B | 101.77 |
| MacroGenics (MGNX) | United States | $0.792B | 0.00 |
| Omeros (OMER) | United States | $0.770B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.662B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.660B | 22.57 |
| LeMaitre Vascular (LMAT) | United States | $0.542B | 26.97 |
| Lantheus Holdings (LNTH) | United States | $0.517B | 16.07 |
| NanoString Technologies (NSTG) | United States | $0.452B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.445B | 0.00 |
| Quanterix (QTRX) | United States | $0.398B | 0.00 |
| Evolus (EOLS) | United States | $0.354B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.325B | 20.90 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.323B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.321B | 0.00 |
| Surface Oncology (SURF) | United States | $0.220B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.218B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.204B | 0.00 |
| Bovie Medical (BVX) | United States | $0.173B | 0.00 |
| Chimerix (CMRX) | United States | $0.173B | 0.00 |
| Fonar (FONR) | United States | $0.149B | 7.32 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.144B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.137B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 17.61 |
| Female Health (VERU) | United States | $0.075B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.074B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.071B | 21.31 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.070B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.062B | 0.00 |
| Neurotrope (NTRP) | United States | $0.057B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.034B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.031B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.027B | 0.00 |
| Myomo (MYO) | United States | $0.023B | 0.00 |
| Senestech (SNES) | United States | $0.020B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
